Skip to content

If monitoring the depth of anesthesia guided by BISPCTRAL INDEX during the operation of abdominal malignant tumor can affect the anesthesia safety and surgical outcome of high risk patients: a randomized, controlled, double-blind trial

If monitoring the depth of anesthesia guided by BISPCTRAL INDEX during the operation of abdominal malignant tumor can affect the anesthesia safety and surgical outcome of high risk patients: a randomized, controlled, double-blind trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032977
Enrollment
Unknown
Registered
2020-05-17
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

deep anesthesia

Interventions

experimental group:depth of anesthesia guided by BIS
control group:depth of anesthesia guided by clinical experience

Sponsors

The First Affiliated Hospital of Shantou University Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective abdominal surgery; 2. Patients with malignant tumor aged more than 60 under general anesthesia; 3. Hospitalization time >= 2 days; 4. Operation time (from the beginning of anesthesia to the end of suture) >= 2 hours; 5. POSPOM score was between 30 and 40; 6. Intravenous anesthesia was used in the maintenance phase of anesthesia.

Exclusion criteria

Exclusion criteria: 1. The intended surgical operation or patient position cannot be monitored using Bis, or patients who need to be awakened during surgery; 2. The anesthesia maintenance type is not intravenous anesthesia; 3. Patients who took other test drugs or participated in other clinical trials 3 months before enrollment; 4. Any Patients who disagree with or cooperate with the study or the investigators consider him(her) inappropriate to be included in this trial.

Design outcomes

Primary

MeasureTime frame
one-year mortality and the incidence of tumor reccurrence;

Countries

China

Contacts

Public ContactCheng Minghua

Department of Anesthesiology, The First Affiliated Hospital of Shantou University Medical College

minghuacheng@sina.com+86 13643038812

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026